Sparrow Pharmaceuticals Funding: $50M Raised, Series A
Sparrow Pharmaceuticals is a Biotech company based in Portland, Oregon. It has raised $50M in total funding. Latest round: Series A. Backed by OrbiMed.
Sparrow Pharmaceuticals funding overview
Sparrow Pharmaceuticals is a Biotech company based in Portland, Oregon. Sparrow Pharmaceuticals has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Sparrow Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include OrbiMed.
Sparrow Pharmaceuticals at a glance
Total raised
$50M
Latest round
Series A
Latest round date
May 2021
Industry
Biotech
Headquarters
Portland, Oregon
Notable investors
OrbiMed
Frequently asked about Sparrow Pharmaceuticals funding
How much has Sparrow Pharmaceuticals raised?
Sparrow Pharmaceuticals has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Sparrow Pharmaceuticals?
OrbiMed are named among the investors backing Sparrow Pharmaceuticals.
What was the latest Sparrow Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in May 2021.
Where is Sparrow Pharmaceuticals based?
Sparrow Pharmaceuticals is based in Portland, Oregon.
What sector does Sparrow Pharmaceuticals operate in?
Sparrow Pharmaceuticals is tracked under Biotech from Portland, Oregon, with $50M in disclosed funding.
When did Sparrow Pharmaceuticals last raise?
The last disclosed Sparrow Pharmaceuticals round closed in May 2021 at Series A.
Round data for Sparrow Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Portland and backer lists below.
